Novel educational video module about alcohol use disorder increases treatment rates and decreases return to alcohol use

doi:10.4254/wjh.v17.i10.109583

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 10

This Article

(42)

(56)

(0)

(628)

(2)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Hepatol. Oct 27, 2025; 17(10): 109583
Published online Oct 27, 2025. doi: 10.4254/wjh.v17.i10.109583

Table 2 Treatment education for alcohol misuse cohort outcomes by treatment type, n (%)

Outcome variable	Treatment group					Total (n = 42)	P value¹
	No treatment none (n = 6)	Treatment
	No treatment none (n = 6)	Pharmacologic (n = 21)	Behavioral (n = 31)	Both (n = 17)	Any treatment (n = 36)
30-day follow-up							1.001²
Attempted, unsuccessful	0 (0.0)	2 (9.5)	0 (0.0)	0 (0.0)	2 (5.7)	2 (4.9)
Successful	6 (100.0)	19 (90.5)	30 (100.0)	17 (100.0)	33 (94.3)	39 (95.1)
Missing	0	0	1	0	1	1
Recall drinks							0.862³
N (missing)	6 (0)	18 (3)	28 (3)	16 (1)	31 (5)	37 (5)
Median (IQR)	0.0 (0.0, 0.0)	0.0 (0.0, 0.0)	0.0 (0.0, 0.0)	0.0 (0.0, 0.0)	0.0 (0.0, 0.0)	0.0 (0.0, 0.0)
Ethanol
N (missing)	2 (4)	9 (12)	12 (19)	7 (10)	14 (22)	16 (26)	-
Median (IQR)	103.0 (0.0, 206.0)	0.0 (0.0, 162.0)	0.0 (0.0, 81.0)	0.0 (0.0, 0.0)	0.0 (0.0, 162.0)	0.0 (0.0, 174.0)	-
Phosphatidylethanol (pETH)
N (missing)	1 (5)	3 (18)	9 (22)	3 (14)	9 (27)	10 (32)	-
Median (IQR)	14.0 (14.0, 14.0)	0.0 (0.0, 0.0)	0.0 (0.0, 14.0)	0.0 (0.0, 0.0)	0.0 (0.0, 0.0)	0.0 (0.0, 14.0)	-
Outpatient follow-up visit							0.371²
No	5 (83.3)	10 (50.0)	14 (50.0)	6 (37.5)	18 (54.5)	23 (59.0)
Yes	1 (16.7)	10 (50.0)	14 (50.0)	10 (62.5)	15 (45.5)	16 (41.0)
Missing	0	1	3	1	3	3
30-day readmission							1.001²
No	4 (66.7)	14 (66.7)	21 (67.7)	12 (70.6)	25 (69.4)	29 (69.0)
Yes	2 (33.3)	7 (33.3)	10 (32.3)	5 (29.4)	11 (30.6)	13 (31.0)
30-day mortality							1.001²
No	6 (100.0)	21 (100.0)	29 (93.5)	17 (100.0)	34 (94.4)	40 (95.2)
Yes	0 (0.0)	0 (0.0)	2 (6.5)	0 (0.0)	2 (5.6)	2 (4.8)
30-day relapse							0.411²
No	5 (83.3)	17 (89.5)	27 (93.1)	16 (94.1)	30 (93.8)	35 (92.1)
Yes	1 (16.7)	2 (10.5)	2 (6.9)	1 (5.9)	2 (6.3)	3 (7.9)
Missing	0	2	2	0	4	4
Found the module helpful							0.391²
No	1 (16.7)	1 (5.3)	2 (6.5)	1 (5.9)	2 (5.9)	3 (7.5)
Yes	5 (83.3)	18 (94.7)	29 (93.5)	16 (94.1)	32 (94.1)	37 (92.5)
Missing	0	2	0	0	2	2
Recommend the module
Yes	6 (100.0)	19 (100.0)	31 (100.0)	17 (100.0)	34 (100.0)	40 (100.0)	-
Missing	0	2	0	0	2	2	-

¹P values are represented as comparisons made between the no treatment group and the any treatment group.

²Fisher exact P value.

³Wilcoxon rank sum P value.

N (missing): Number of patients (missing patients); IQR: Interquartile range; pETH: Phosphatidylethanol level.

Full Size Table

Citation: Twohig P, Slocum ZP, Willet A, Schissel M, Balasanova AA, Scholten K, Warner J, Sempokuya T, Khoury N, Ashford A, Peeraphatdit TB. Novel educational video module about alcohol use disorder increases treatment rates and decreases return to alcohol use. World J Hepatol 2025; 17(10): 109583
URL: https://www.wjgnet.com/1948-5182/full/v17/i10/109583.htm
DOI: https://dx.doi.org/10.4254/wjh.v17.i10.109583

Twohig P, Slocum ZP, Willet A, Schissel M, Balasanova AA, Scholten K, Warner J, Sempokuya T, Khoury N, Ashford A, Peeraphatdit TB. Novel educational video module about alcohol use disorder increases treatment rates and decreases return to alcohol use. World J Hepatol 2025; 17(10): 109583 [PMID: 41179735 DOI: 10.4254/wjh.v17.i10.109583]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.